Doroshow DB, Wei W, Gupta S, Zugazagoitia J, et al. PD-L1 tumor proportion score and overall survival from first-line pembrolizumab in patients with nonsquamous versus squamous non-small cell lung cancer. J Thorac Oncol 2021 Aug 26. pii: S1556-0864(21)02392.
PMID: 34455068